Metro

  • Written by Sharona Hoffman, Professor of Health Law and Bioethics, Case Western Reserve University

My husband, Andy, has Parkinson’s disease. A year ago, his neurologist recommended a new pill that he was to take at bedtime. We quickly learned that the medication would cost US$1,300 for a one-month supply of 30 pills. In addition, Andy could obtain the drug from only one specialty pharmacy and would have to use mail order.

This was our introduction to specialty drugs.

These medications are becoming increasingly common, though many Americans are unfamiliar with the term. In 2018, the Food and Drug Administration approved 59 new medications[1], of which 39 are considered specialty drugs[2].

Specialty drugs[3] are generally high-cost drugs requiring special handling such as refrigeration or injection, though Andy’s did not. They treat complex conditions such as cancer and multiple sclerosis[4].

Specialty drugs are often available only through specialty pharmacies. In addition to filling prescriptions, these outlets provide educational and support services[5] to patients. For example, they provide refill reminders and help patients learn how to inject their drugs.

In a forthcoming article[6], professor Isaac Buck[7] and I argue that specialty drugs raise significant legal and ethical questions. These merit attention from the public and policymakers.

High-priced specialty drugs: Exposing the flaws in the system Pharmacy benefits managers exert great influence on how and where consumers get their prescriptions filled. David Smart/Shutterstock.com[8]

Specialty drug concerns

First, the term “specialty drug” is somewhat elusive and has no clear definition. In addition, government authorities and medical experts are not the ones who decide whether a medication is designated a specialty drug. Rather, the decision is entirely up to pharmacy benefit managers[9], or PBMs.

PBMs[10] administer health plans’ drug benefit programs and thereby serve insurers. PBMs have been criticized[11] for driving up health care costs. Drugs that are specialty drugs under one insurance policy are sometimes classified differently[12] in other policies. Furthermore, some specialty drugs are simple pills that do not involve complicated instructions, and thus, it is unclear why they are categorized as specialty drugs.

The second problem is the very high cost of specialty drugs. The average price tag of the more than 300 medications[13] that are considered specialty drugs is approximately $79,000[14] per year. Almost half[15] of the dollars that Americans pay for medications are spent on specialty drugs. In fact, Medicare spent $32.8 billion[16] on specialty drugs in 2015.

Because of these exorbitant costs, some insurers have created what they call a “specialty tier[17]” in their health plans. In this tier, patients’ cost-sharing responsibilities are higher[18] than they are for medications in other tiers. If your drug is placed in a specialty tier, your coinsurance[19] payment, or the percentage of cost that you pay, may be 25% to 33%[20] of the drug’s price.

This leads to a situation in which you may have the least generous insurance coverage for your most expensive drugs. Under some plans you might pay[21] $10 per month for generic drugs but hundreds of dollars per month for specialty drugs. This can translate into many thousands of dollars[22] in annual out-of-pocket costs, even for consumers with good health insurance. There are no federal regulations in the U.S. that limit drug prices or insurers’ tiering practices.

Conflict of interest and patient choice

A third problem is conflict of interest. PBMs own or co-own[23] the top four specialty pharmacies in the U.S., which are responsible for two-thirds[24] of nationwide specialty drug prescription revenues.

PBMs frequently require[25] patients to purchase their medications from the specific specialty pharmacy that they own. Thus, PBMs have much to gain from designating medications as specialty drugs. Doing so may lead to significant revenues in the form of purchases at PBM-owned specialty pharmacies.

A related problem is the limiting of patient choice. Many specialty pharmacies fill prescriptions only through mail order[26]. Consequently, patients may be restricted to using just one pharmacy and be forced to rely on the mail for delivery.

Some patients enjoy the convenience of home delivery. Others, however, prefer the traditional approach of visiting a drugstore in person. They may worry that the mail will be late, their package will be stolen, or they will be out of town when the drugs arrive. Yet, such patients do not have the option of a brick and mortar pharmacy.

High-priced specialty drugs: Exposing the flaws in the system Medicare drug plans cannot force seniors to use mail-order pharmacies. The practice limited their choices and led to higher prices in some instances. Image Point FR[27]

Possible corrective measures

Both political parties have stated that health care costs are a priority for them. However, they have shown a limited appetite for tackling this herculean problem.

The House recently passed a bill[28] that would enable the federal government to negotiate prices with drug manufacturers. Such negotiations could well lower specialty drug prices. The Senate, however, is unlikely to approve the bill, and Congress is unlikely to pass sweeping legislation in a divisive election year.

There has been more success at the federal level in promoting consumer choice. Medicare rules establish that Medicare plans may not force[29]participants to use mail-order pharmacies.

In the meantime, individual states offer useful solutions. For example, some have provided patients with relief in the form of capping out-of-pocket costs. California[30] limits consumers’ expenditures to $250 or $500 for a 30-day supply, depending on the drug type.

At least 15 states also have pharmacy choice statutes. Several ban[31] PBM mandates that prevent patients from freely selecting their preferred qualified pharmacy. Many ban[32] mail-order only requirements.

Some states have recognized that PBMs should not be entirely free to designate medications as specialty drugs. Because such designations can significantly disadvantage patients and may increase patients’ costs, such states have statutory definitions for the term “specialty drug.”

They generally mandate[33] that the drug require special administration, delivery, storage or oversight. Such requirements may justify purchase from a specialty pharmacy. However, drugs without complicated instructions should not be deemed specialty drugs.

One more option that some insurers have already adopted is allowing patients to obtain just a few pills or doses for an initial trial period. Sometimes individuals quickly learn that they cannot tolerate a medication or that it is ineffective. Such “partial fill[34]” programs can spare patients the exorbitant cost of a full 30-day specialty drug supply.

Specialty drugs contribute significantly to the American health care cost crisis. Additional state, or better yet, federal laws should be enacted to constrain PBMs’ authority over specialty drugs. We need further regulation concerning drug classification, pricing, conflicts of interest and patient choice.

[ Insight, in your inbox each day. You can get it with The Conversation’s email newsletter[35]. ]

References

  1. ^ 59 new medications (www.raps.org)
  2. ^ 39 are considered specialty drugs (www.pharmacytimes.com)
  3. ^ Specialty drugs (www.pcmanet.org)
  4. ^ cancer and multiple sclerosis (www.bcbsm.com)
  5. ^ educational and support services (www.pharmacist.com)
  6. ^ forthcoming article (papers.ssrn.com)
  7. ^ professor Isaac Buck (law.utk.edu)
  8. ^ David Smart/Shutterstock.com (www.shutterstock.com)
  9. ^ entirely up to pharmacy benefit managers (www.specialtyrxtoolkit.org)
  10. ^ PBMs (www.pharmacytimes.com)
  11. ^ criticized (ctmirror.org)
  12. ^ classified differently (www.medicare.gov)
  13. ^ 300 medications (www.pewtrusts.org)
  14. ^ $79,000 (www.beckershospitalreview.com)
  15. ^ Almost half (www.pharmacytimes.com)
  16. ^ $32.8 billion (www.cbo.gov)
  17. ^ specialty tier (www.medicare.gov)
  18. ^ higher (www.hemophiliafed.org)
  19. ^ coinsurance (www.healthcare.gov)
  20. ^ 25% to 33% (www.bcbsm.com)
  21. ^ pay (www.bcbsm.com)
  22. ^ thousands of dollars (www.kff.org)
  23. ^ own or co-own (drugchannelsinstitute.com)
  24. ^ two-thirds (drugchannelsinstitute.com)
  25. ^ require (gustafsongluek.com)
  26. ^ mail order (www.nytimes.com)
  27. ^ Image Point FR (www.shutterstock.com)
  28. ^ bill (www.nytimes.com)
  29. ^ may not force (www.medicare.gov)
  30. ^ California (law.justia.com)
  31. ^ ban (law.justia.com)
  32. ^ ban (legislature.idaho.gov)
  33. ^ mandate (www.revisor.mn.gov)
  34. ^ partial fill (www.preferredone.com)
  35. ^ You can get it with The Conversation’s email newsletter (theconversation.com)

Authors: Sharona Hoffman, Professor of Health Law and Bioethics, Case Western Reserve University

Read more http://theconversation.com/high-priced-specialty-drugs-exposing-the-flaws-in-the-system-129598

Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more

Entertainment News

TED CLINE ... Country Music Done Right

Country Music Done Right When Ted Cline uses the phrase “Country Music Done Right” to describe his engaging vibe, the Kansas City area-based singer/songwriter isn’t simply being crafty or clev...

News Company - avatar News Company

LAMONT DOZIER, JR. “Why Can’t We Be Lovers”/”I’m Gonna Take My Time”

When it comes to enduring musical legacies, it’s always inspiring when the melodic, grooving evergreen apples drop so close to the tree. The son and namesake of legendary singer, songwriter and re...

News Company - avatar News Company

DAWGGONEDAVIS ft. Chago G Williams (Rap Master, Producer)

“Darkest Hour” Just a little over two years since Rebecca “DawgGoneDavis” first took the world (and the World & Euro Indie charts) by storm with her quirky and infectious debut single “Mi...

News Company - avatar News Company

Stephen Wrench “Burning Bridges”

When the true colors of people you thought were nice and kind become the latest casualties of your Facebook friends list, the gloves just have to come off. As Stephen Wrench so powerfully and bl...

News Company - avatar News Company

Indulgent Fool Gasoline Tequila

Indulgent Fool,” the latest release from Gasoline Tequila, uses the emotive language of guitar to tell a story about sensuality and courtship. Any given night, in any given room, can define an arti...

News Company - avatar News Company

Chelsey Green and The Green Project release fresh new EP, ReEnvisioned

Chelsey Green and The Green Project. Their fresh new EP, ReEnvisioned, is a dynamic and empowering collection that in only four tracks showcases their passions for contemporary and traditional jazz...

News Company - avatar News Company

Fresh Prince of Bel Air's original "Aunt Viv" Janet Hubert announces new animation project

‘JG and the BC Kids’ Starts Preproduction with Toonz Media Group, Elijah Rock Productions and Ericka Nicole Malone Entertainment to Inspire Children to Embrace Themselves and Others  ...

News Company - avatar News Company

ANGELA PREDHOMME - It’s just So Good To Be Free

There’s something powerful and inspiring about an independent artist who pursues her passion and finds widespread success on her own terms, rather than following the generally accepted mainstream ...

News Company - avatar News Company

In the midst of the COVID-19 pandemic, Pure Mission Entertainment’s Willie J releases “In The Morning”

“In the Morning” To borrow from a well-known spiritual cliché, sometimes the musical muse works in mysterious ways. When Willie J joined forces in 2019 with Atlanta producer Cool Kid Diddy and...

Tom Estey - avatar Tom Estey

Metropolitan Business News

MODEL/ACTOR THORN CASTILLO IS THE “NEW FACE” OF SCHICK STYLIST

In 2019, just as his multi-faceted career was taking off, Thorn Castillo heard Robert Downey Jr. offer a sage bit of advice during an interview on photographer/director Sam Jones’ acclaimed multi-...

News Company - avatar News Company

New Research Highlights Opportunities for Sports Betting

Revenue Stream for Sports’ Post-COVID-19 Recovery Strategies New Rochelle, NY, June 1, 2020— Twenty-four states have now legalized sports betting, with more states considering legalization la...

Len Stein - avatar Len Stein

How to make overseas transfers easier?

Mainstream banks can charge as much as $20 just to process a basic international money transfer. Fortunately, today people are not doomed to handling personal finances only through mainstream gl...

News Company - avatar News Company

The flourishing international market of fragrance and perfume

There is something special and unique about the art of fragrance. This is a big world and there are quite literally a lot of smells around at any given time. In fact, as one of the five human senses i...

News Company - avatar News Company

Impact of good marketing on sales

Sales and marketing are brothers as they go hand and in hand. The job of both of these departments is to generate revenue so that an organization can make money. A company that does not generate rev...

News Company - avatar News Company

7 effective tips for increasing sales in retail

It seems that retailers have drawn a difficult lot in the 21st century: competition from online retail is growing steadily. After all, Internet retailers can sell your products at significantly lowe...

News Company - avatar News Company

Holidays

5 COOL GADGETS TO CARRY FOR A SAFE TRIP

Are you planning to go on a trip? Possibly, you do not know what things are most necessary on a trip. In this article, we will guide you through some important tips. These tips help you to...

News Company - avatar News Company

New Baggage Regulations to Help Aussie Parents Travel with Infants

Travelling around the globe has never been easy, especially when infants tag along for the trip. One of the main issues that parents often have to deal with is the need to bring extra item...

News Company - avatar News Company

Maya Beach Opens to Tourists

Despite recent reports that Southern Thailand's famous Maya Beach will close for three months this year, in fact no decision to this effect has been made by Thai authorities. Phi Phi Nati...

Maevadi Rosenfeldt - avatar Maevadi Rosenfeldt